Canada
· Delayed Price · Currency is CAD Thermo Fisher Scientific Statistics
Total Valuation
Thermo Fisher Scientific has a market cap or net worth of CAD 288.09 billion. The enterprise value is 329.74 billion.
| Market Cap | 288.09B |
| Enterprise Value | 329.74B |
Important Dates
The next estimated earnings date is Wednesday, January 29, 2025.
| Earnings Date | Jan 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -1.16% |
| Shares Change (QoQ) | +0.26% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 381.70M |
Valuation Ratios
The trailing PE ratio is 34.80.
| PE Ratio | 34.80 |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 20.90, with an EV/FCF ratio of 31.43.
| EV / Earnings | 39.83 |
| EV / Sales | 5.41 |
| EV / EBITDA | 20.90 |
| EV / EBIT | 31.40 |
| EV / FCF | 31.43 |
Financial Position
The company has a current ratio of 1.63, with a Debt / Equity ratio of 0.72.
| Current Ratio | 1.63 |
| Quick Ratio | 1.13 |
| Debt / Equity | 0.72 |
| Debt / EBITDA | 3.21 |
| Debt / FCF | 4.57 |
| Interest Coverage | 5.05 |
Financial Efficiency
Return on equity (ROE) is 12.94% and return on invested capital (ROIC) is 5.58%.
| Return on Equity (ROE) | 12.94% |
| Return on Assets (ROA) | 4.67% |
| Return on Capital (ROIC) | 5.58% |
| Revenue Per Employee | 468,640 |
| Profits Per Employee | 67,857 |
| Employee Count | 122,000 |
| Asset Turnover | 0.43 |
| Inventory Turnover | 4.64 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 20.27 |
| 200-Day Moving Average | 21.48 |
| Relative Strength Index (RSI) | 42.83 |
| Average Volume (20 Days) | 15,872 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.05 |
Income Statement
In the last 12 months, Thermo Fisher Scientific had revenue of CAD 57.17 billion and earned 8.28 billion in profits. Earnings per share was 21.53.
| Revenue | 57.17B |
| Gross Profit | 23.26B |
| Operating Income | 9.96B |
| Pretax Income | 9.12B |
| Net Income | 8.28B |
| EBITDA | 14.28B |
| EBIT | 9.96B |
| Earnings Per Share (EPS) | 21.53 |
Balance Sheet
The company has 8.97 billion in cash and 47.92 billion in debt, giving a net cash position of -38.95 billion.
| Cash & Cash Equivalents | 8.97B |
| Total Debt | 47.92B |
| Net Cash | -38.95B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 66.25B |
| Book Value Per Share | 172.84 |
| Working Capital | 12.39B |
Cash Flow
In the last 12 months, operating cash flow was 12.28 billion and capital expenditures -1.79 billion, giving a free cash flow of 10.49 billion.
| Operating Cash Flow | 12.28B |
| Capital Expenditures | -1.79B |
| Free Cash Flow | 10.49B |
| FCF Per Share | n/a |
Margins
Gross margin is 40.68%, with operating and profit margins of 17.42% and 14.48%.
| Gross Margin | 40.68% |
| Operating Margin | 17.42% |
| Pretax Margin | 15.95% |
| Profit Margin | 14.48% |
| EBITDA Margin | 24.98% |
| EBIT Margin | 17.42% |
| FCF Margin | 18.35% |
Dividends & Yields
Thermo Fisher Scientific does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 9.29% |
| Buyback Yield | 1.16% |
| Shareholder Yield | 1.16% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Thermo Fisher Scientific has an Altman Z-Score of 3.97.
| Altman Z-Score | 3.97 |
| Piotroski F-Score | n/a |